Breast, Omega 3 Free Fatty Acid, Ph 0

Completed · Not applicable

Conditions studied: Breastcancer

In brief

Assess the impact of dietary omega 3 free fatty acids breast cancer patients.

Key facts

Study ID

NCT02996240

Run by

The University of Texas Health Science Center at San Antonio

People needed

21

Starts

2017-06-12

Expected to finish

2021-02-22

Last updated by the study team

2021-03-17

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• ECOG ≤2
• Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee
• Consented for tissue collection on CTRC repository 07-32

You may not qualify if…

• Active systemic illness (infection including viral illnesses such as Hepatitis and HIV)
• Chronic use of NSAIDs or omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days)
• Any NSAIDs or omega-3 free fatty acid supplementation within the last 14 days
• History of medical noncompliance
• Scheduled date of surgical resection that would limit the amount of time taking the intervention to less than 21 days

Where it is running

• CTRC at University of Texas Health Science Center San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.